These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


327 related items for PubMed ID: 21887456

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
    Li Y, Li A, Strait K, Zhang H, Nanes MS, Weitzmann MN.
    J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
    [Abstract] [Full Text] [Related]

  • 3. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK, Wan CK, Shen XL, Yang M, Fong WF.
    Biochem Pharmacol; 2005 Nov 15; 70(10):1443-57. PubMed ID: 16181613
    [Abstract] [Full Text] [Related]

  • 4. The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κB activation.
    Yamaguchi M, Weitzmann MN.
    Int J Mol Med; 2012 Sep 15; 30(3):708-12. PubMed ID: 22751682
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-κB activation and cytokine production of glial cells.
    Zhang P, Liu X, Zhu Y, Chen S, Zhou D, Wang Y.
    Neurosci Lett; 2013 Feb 08; 534():123-7. PubMed ID: 23262090
    [Abstract] [Full Text] [Related]

  • 7. Anti-inflammatory effect of 4-O-methylhonokiol, compound isolated from Magnolia officinalis through inhibition of NF-kappaB [corrected].
    Oh JH, Kang LL, Ban JO, Kim YH, Kim KH, Han SB, Hong JT.
    Chem Biol Interact; 2009 Aug 14; 180(3):506-14. PubMed ID: 19539808
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities.
    Kumar A, Kumar Singh U, Chaudhary A.
    Future Med Chem; 2013 May 14; 5(7):809-29. PubMed ID: 23651094
    [Abstract] [Full Text] [Related]

  • 12. Honokiol ameliorates endothelial dysfunction through suppression of PTX3 expression, a key mediator of IKK/IκB/NF-κB, in atherosclerotic cell model.
    Qiu L, Xu R, Wang S, Li S, Sheng H, Wu J, Qu Y.
    Exp Mol Med; 2015 Jul 03; 47(7):e171. PubMed ID: 26138903
    [Abstract] [Full Text] [Related]

  • 13. Anti-psoriatic effects of Honokiol through the inhibition of NF-κB and VEGFR-2 in animal model of K14-VEGF transgenic mouse.
    Wen J, Wang X, Pei H, Xie C, Qiu N, Li S, Wang W, Cheng X, Chen L.
    J Pharmacol Sci; 2015 Jul 03; 128(3):116-24. PubMed ID: 26220468
    [Abstract] [Full Text] [Related]

  • 14. Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation.
    Vaid M, Sharma SD, Katiyar SK.
    Carcinogenesis; 2010 Nov 03; 31(11):2004-11. PubMed ID: 20823108
    [Abstract] [Full Text] [Related]

  • 15. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway.
    Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL, Aggarwal BB.
    Mol Cancer Res; 2006 Sep 03; 4(9):621-33. PubMed ID: 16966432
    [Abstract] [Full Text] [Related]

  • 16. Novel curcumin analogue UBS109 potently stimulates osteoblastogenesis and suppresses osteoclastogenesis: involvement in Smad activation and NF-κB inhibition.
    Yamaguchi M, Moore TW, Sun A, Snyder JP, Shoji M.
    Integr Biol (Camb); 2012 Aug 03; 4(8):905-13. PubMed ID: 22751853
    [Abstract] [Full Text] [Related]

  • 17. Quercetin, a potent suppressor of NF-κB and Smad activation in osteoblasts.
    Yamaguchi M, Weitzmann MN.
    Int J Mol Med; 2011 Oct 03; 28(4):521-5. PubMed ID: 21769418
    [Abstract] [Full Text] [Related]

  • 18. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH, Zheng MH, Feng HT, Steer JH, Joyce DA, Xu J.
    J Bone Miner Res; 2004 Nov 03; 19(11):1905-16. PubMed ID: 15476591
    [Abstract] [Full Text] [Related]

  • 19. RANKL-induced osteoclastogenesis is suppressed by 4-O-methylhonokiol in bone marrow-derived macrophages.
    Park KR, Kim JY, Kim EC, Yun HM, Hong JT.
    Arch Pharm Res; 2017 Aug 03; 40(8):933-942. PubMed ID: 28736799
    [Abstract] [Full Text] [Related]

  • 20. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH.
    Mol Pharmacol; 2010 Jan 03; 77(1):17-25. PubMed ID: 19828731
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.